Cutaneous recurrence of long term pulmonary sarcoidosis - literature review and case report
DOI:
https://doi.org/10.12775/JEHS.2023.46.01.013Keywords
sarcoidosis, skin lessions, lymphadenopathyAbstract
Sarcoidosis is a systemic granulomatous disease, the exact etiology of which is unknown. This paper presents a case of a patient with a long course of pulmonary sarcoidosis with exacerbation of the disease in the form of skin lesions.
A 50-year-old female patient was admitted to the Department of Tuberculosis and Lung Diseases, Medical University of Lublin, because of cervical lymphadenopathy. Based on the histopathological examination, she was diagnosed with sarcoidosis. The patient reported constant fatigue, throat tightness and difficulty swallowing, as well as decreased exercise tolerance. Computed tomography studies revealed small nodular changes in both lungs and mediastinal lymphadenopathy. The patient was actively monitored. The results of spirometry tests improved spontaneously and remained at a satisfactory level for years. After 15 years of follow-up, the patient reported skin lesions that are constantly progressing. Examination of the cut from the skin lesion confirmed skin sarcoidosis.
This case report highlights the varied course of sarcoidosis, which, as a multi-system disease, may show various manifestations. In clinical practice, therefore, one should consider the possibility of disease progression and transmission to multiple organs. It is important that the patient is under constant observation and that new lesions undergo differential diagnosis and histopathological examination.
References
Jain R, Yadav D, Puranik N, Guleria R, Jin J. Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments. J Clin Med. 2020; 9: 1081 . doi: 10.3390/jcm9041081. PMID: 32290254; PMCID: PMC7230978
Stefański M, Stefańska M, Bruliński K. Etiology, pathogenesis and diagnosis of sarcoidosis – review of the literature. Borgis - Medycyna Rodzinna. 2016; 2: 98-105
Bokhari SRA, Zulfiqar H, Mansur A. Sarcoidosis. 2021 May 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 28613460.
Celada LJ, Kropski JA, Herazo-Maya JD, et al. PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production. Sci Transl Med. 2018 Sep 26;10(460):eaar8356. doi: 10.1126/scitranslmed.aar8356. PMID: 30257954; PMCID: PMC6263177.
Polverino F, Balestro E, Spagnolo P. Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art. J Clin Med. 2020 Jul 24;9(8):2363. doi: 10.3390/jcm9082363. PMID: 32722050; PMCID: PMC7465477.
Piotrowski W.J. Radiological examinations in the diagnosis and monitoring of pulmonary sarcoidosis. Pol Merkur Lekarski 2018 Mar 27;44(261):118-123. Polish. PMID: 29601560.
Hubail A, Belkharoeva R, Tepluk N, Belerosova T. Lupus pernio (Besnier-Tenneson syndrome): A rare form of sarcoidosis. Dermatol Reports. 2018 Oct 1;10(2):7696. doi: 10.4081/dr.2018.7696. PMID: 30555667; PMCID: PMC6250080.
Hamzeh N, Steckman DA, Sauer WH, Judson MA. Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol. 2015 May;12(5):278-88. doi: 10.1038/nrcardio.2015.22. Epub 2015 Feb 24. PMID: 25707386.
Kandolin R, Lehtonen J, Airaksinen J et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015 Feb 17;131(7):624-32. doi: 10.1161/CIRCULATIONAHA.114.011522. Epub 2014 Dec 19. PMID: 25527698.
Ungprasert P, Crowson CS, Matteson EL. Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013. Neuroepidemiology. 2017;48(3-4):87-94. doi: 10.1159/000477300. Epub 2017 Jun 10. PMID: 28601860; PMCID: PMC5575952.
Gerke AK. Treatment of Sarcoidosis: A Multidisciplinary Approach. Front Immunol. 2020 Nov 19;11:545413. doi: 10.3389/fimmu.2020.545413. PMID: 33329511; PMCID: PMC7732561.
James WE, Judson MA. Therapeutic strategies for pulmonary sarcoidosis. Expert Rev Respir Med. 2020 Apr;14(4):391-403. doi: 10.1080/17476348.2020.1721284. Epub 2020 Jan 31. PMID: 32003264.
Grutters JC, van den Bosch JM. Corticosteroid treatment in sarcoidosis. Eur Respir J. 2006 Sep;28(3):627-36. doi: 10.1183/09031936.06.00105805. PMID: 16946094.
Gerke AK, Hunninghake G. The immunology of sarcoidosis. Clin Chest Med. 2008 Sep;29(3):379-90, vii. doi: 10.1016/j.ccm.2008.03.014. PMID: 18539233.
Judson MA, Chaudhry H, Louis A, Lee K, Yucel R. The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis. Respir Med. 2015 Apr;109(4):526-31. doi: 10.1016/j.rmed.2015.01.019. Epub 2015 Feb 7. PMID: 25698652; PMCID: PMC4447298.
Brito-Zerón P, Pérez-Alvarez R, Pallarés L, Retamozo S, Baughman RP, Ramos-Casals M; SarcoGEAS-SEMI Study Group. Sarcoidosis: an update on current pharmacotherapy options and future directions. Expert Opin Pharmacother. 2016 Dec;17(18):2431-2448. doi: 10.1080/14656566.2016.1258061. PMID: 27817209.
Goljan-Geremek A, Bednarek M, Franczuk M, et al. Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study. Pneumonol Alergol Pol. 2014;82(6):518-33. doi: 10.5603/PiAP.2014.0069. PMID: 25339562.
Hamzeh N, Voelker A, Forssén A, Gottschall EB, Rose C, Mroz P, Maier LA. Efficacy of mycophenolate mofetil in sarcoidosis. Respir Med. 2014 Nov;108(11):1663-9. doi: 10.1016/j.rmed.2014.09.013. Epub 2014 Sep 28. PMID: 25301291; PMCID: PMC4254196.
Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020 Mar;16(3):155-166. doi: 10.1038/s41584-020-0372-x. Epub 2020 Feb 7. PMID: 32034323.
Baughman RP, Lower EE. Evidence-based therapy for cutaneous sarcoidosis. Clin Dermatol. 2007 May-Jun;25(3):334-40. doi: 10.1016/j.clindermatol.2007.03.011. PMID: 17560311.
Baughman RP, Judson MA, Lower EE, et al. Sarcoidosis Investigators. Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 15;32(4):289-95. PMID: 26847095.
Crommelin HA, van der Burg LM, Vorselaars AD, et al. Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab. Respir Med. 2016 Jun;115:72-7. doi: 10.1016/j.rmed.2016.04.011. Epub 2016 Apr 23. PMID: 27215507.
Pariser RJ, Paul J, Hirano S, Torosky C, Smith M. A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis. J Am Acad Dermatol. 2013 May;68(5):765-73. doi: 10.1016/j.jaad.2012.10.056. Epub 2012 Dec 28. PMID: 23276549.
Prasse A. The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis. Dtsch Arztebl Int. 2016 Aug 22;113(33-34):565-74. doi: 10.3238/arztebl.2016.0565. PMID: 27598883; PMCID: PMC5015588.
Buss G, Cattin V, Spring P, Malinverni R, Gilliet M. Two cases of interferon-alpha-induced sarcoidosis Koebnerized along venous drainage lines: new pathogenic insights and review of the literature of interferon-induced sarcoidosis. Dermatology. 2013;226(4):289-97. doi: 10.1159/000346244. Epub 2013 Jul 23. PMID: 23886768.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Julia Bargieł, Justyna Cabaj, Izabela Chmielewska, Marta Adamczyk-Korbel, Anna Grzywa-Celińska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 269
Number of citations: 0